Clinical Trial

A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-11
critical Primary endpoint(s) modified 2026-05-23
Trial Details
NCT Number NCT07594769
Lead Sponsor Pfizer
Conditions Migraine
Enrollment 36 participants
Start Date 2026-05-08
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10